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NATIONAL CANCER INSTITUTE 
Strategic Plan to Reduce and 
Ultimately Eliminate Health Disparities 
 
NCI MISSION/VISION STATEMENT 
 
The National Cancer Institute’s (NCI) mission is to stimulate and support scientific discovery 
and its application to achieve a future when all cancers are uncommon and easily treated.  The 
fact that the burden of cancer is borne unequally in our society is not only a challenge to science 
but a moral and ethical dilemma for our Nation.  The overarching goal of the NCI articulated in 
this Strategic Plan is to understand the causes of cancer health disparities and develop effective 
interventions to reduce and, ultimately, eliminate them.  To accomplish this goal, NCI will invest 
in research to examine the inequalities in cancer and the social, cultural, environmental, 
biological, and behavioral determinants of cancer, the interactions among them, and the 
mechanisms by which they contribute to disparities in cancer care and prevention.  Further, NCI 
will support initiatives to develop sustainable interventions, and identify priority areas for future 
policy development that are based on scientific and expert evidence to ameliorate cancer health 
disparities.   
    
OVERVIEW OF NCI STRATEGY FOR ADDRESSING HEALTH DISPARITIES 
 
The Overall Challenge  
 
Despite progress in biomedical science over the past several decades that has increased longevity 
and improved quality of life for many in our Nation, a heavier burden of disease continues to be 
borne by some populations, particularly minorities, the poor and underserved.  For example, the 
death rate from prostate cancer among African American men is almost twice that of white men, 
and stomach cancer mortality is substantially higher among Asian-Pacific Islanders, including 
Native Hawaiians, than other populations. Cervical cancer incidence in Hispanic women has 
been consistently higher at all ages than for other women, and African American women have the 
highest death rate from cervical cancer. Overall, men are about 50 percent more likely than 
women to die from cancer, and among all women, Alaskan Natives are about 30 percent more 
likely to die from cancer.  It is these disturbing statistics coupled with the fact that reductions in 
cancer incidence and mortality are occurring in many, but not all, sectors of our Nation, that 
prompts NCI to examine major determinants of cancer health disparities (e.g., poverty, culture, 
and social injustice).  It is the interrelationship among these factors that must be carefully weaved 
into the cancer research agenda in order to remedy the unequal burden of cancer.  
      
The National Cancer Institute is strongly committed to a research program that will address these  
cancer health disparities across the cancer control continuum from prevention to end of life care, 
consistent with recommendations in the Institute of Medicine’s 1999 report, The Unequal Burden 
of Cancer, the Institute of Medicine’s 2002 report, Unequal Treatment, and reflected in the
Healthy People 2010 goal to eliminate racial and ethnic health disparities.  Beginning with the 
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FY 2002 Bypass Budget document (published in October 2000), “Reducing Cancer-related 
Health Disparities” has been highlighted as a major priority “challenge” for the Institute. 
Substantial planning has gone into formulating this document, The Nation’s Investment in
Cancer Research.   Mandated under the National Cancer Act of 1971 (P.L.92-218), this 
document is designed to provide the President each year with a description of scientific 
opportunities in cancer research as he formulates his budget request to Congress.   
 
To direct the implementation and coordination of these activities, support NCI health disparities 
research opportunities, and to provide an organizational locus for NCI in translating discovery 
into delivery, NCI established the Center to Reduce Cancer Health Disparities (CRCHD).  NCI 
intends to expand the capacity of the NCI Center to Reduce Cancer Health Disparities (CRCHD) 
to accomplish these goals.   
 
Through NCI-supported research and extramural programs, CRCHD’s activities are designed to 
develop a better understanding of the causes of disparities and provide scientifically-based 
evidence to support the development of effective strategies to intervene where disparities exist. 
NCI also has established a variety of infrastructures and initiatives to improve understanding of 
disparities and develop strategies and interventions to overcome them. These activities provide a 
firm foundation from which to expand and intensify our efforts as the Institute moves forward to 
“bridging the gap” between research discovery and service delivery.  
 
Major Strategies For Addressing Cancer Health Disparities  
 
The objectives of the NCI aimed at reducing and ultimately eliminating cancer-related health 
disparities will continue to strengthen and expand many ongoing activities, and establish new 
initiatives.  Some initiatives may overlap or  interface with more than one of the categories listed 
below.  For example, an initiative may provide infrastructure for conducting clinical trials aimed 
at developing new or improved approaches to research in  treating cancer.  Moreover, improving 
participation in these trials by ethnic and racial minorities may require communication/outreach 
activities and additional research to understand how best to engage in effective communication, 
education and outreach.  Recognizing that such overlaps may exist, this Plan outlines objectives 
within the following categories: expanding research, building research capacity and 
infrastructure, and expanding community outreach and information dissemination to impact on 
the elimination of cancer health disparities. 
   
RESEARCH: 
 
Disease always occurs within a context of human circumstances.  In combination, risks related to 
genes, individual behaviors, social and environmental circumstances contribute to disease 
susceptibility.  Moreover, social position, economic status, culture, and environment are among 
the more critical determinants of who is born healthy, who grows up healthy, who sustains health 
throughout his or her life span, who survives disease, and who maintains a good quality of life 
after diagnosis and treatment. NCI’s long-term investment in biological research and our more  
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recent investments in behavioral research have helped us make enormous strides in 
understanding how biological and behavioral factors determine risks for developing or dying 
from cancer and how interventions can modify these risks.  Much less is known, however, about 
the effect that factors such as social position, economic status, cultural beliefs and practices, and 
environmental exposures have on cancer risk.  If we are to reduce these disparities, the relative 
importance of social causes to their development and their relation to factors that result in 
unequal access to high quality cancer diagnosis and treatment must be explained. To do this, we 
must increase fundamental research into the social causes of health disparities, the psychosocial 
factors that mediate them, and the biologic pathways that can explain their impact.  
 
NCI has developed and will pursue a research framework that builds upon the growing evidence 
that socioeconomic, cultural, health care provider, institutional, and environmental factors 
contribute substantially to cancer-related health disparities. The elements that influence health 
disparities are complex, and their interactions are largely unknown. While health disparities have 
been framed historically in the context of racial and ethnic disease differences, racial and ethnic 
classifications have always been socially and politically determined and have no legitimate place 
in biological science.  There is broad  agreement among experts that racism, borne of racial and 
ethnic classifications, is rooted in the erroneous concept of biological superiority and is a part of 
the cultural framework of societal, institutional, and civilizational values that continues to shape 
scientific thought.  CRCHD has launched a series of workshops and seminars through which we 
can better address, using new frameworks, the fundamental aspects of population diversity and 
the development of diseases.  The recommendations emerging from these meetings will form the 
foundation for NCI’s research and program development.  The power of scientific discovery 
must be used to elucidate the meaning and effect of the human circumstances in which 
differential disease burdens occur. 
 
In our national effort against cancer, there is a critical disconnect between scientific discovery 
and cancer care delivery, and this disconnect is itself a key determinant of the unequal burden of 
cancer in our society. Barriers that prevent the benefits of research from reaching all populations, 
particularly those who bear the greatest disease burden, must be identified and removed. To 
achieve this objective, CRCHD is designing a “patient navigator” concept patterned after similar 
programs pioneered at Harlem Hospital over 10 years ago.  This program would assist patients 
with abnormal findings or a diagnosis of cancer in navigating and, when needed, 
circumnavigating the hospital and human services bureaucracies to accomplish the necessary 
follow-up and diagnosis of abnormal findings on cancer screening to treatment.  Further, NCI 
will develop new intergovernmental and public/private partnerships to improve the dissemination 
and diffusion of evidence-based interventions and encourage the development of health care 
policies for underserved communities. 
  
In summary, to reduce cancer-related health disparities in our society, we must understand where 
biological, behavioral, social, economic, cultural, and environmental factors interface.  We must 
separate myth from reality to determine what does and does not contribute to these disparities 
and use that insight to develop new interventions.  And we must design new research investments 
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•  The relative importance of social, cultural, and environmental determinants of cancer 
•  How social, cultural, and environmental factors interact with biological and behavioral 
determinants 
•  By what mechanisms social, cultural, and environmental determinants may increase  
  cancer incidence and mortality and contribute to cancer-related health disparities 
 
The Need to Measure and Monitor Cancer Health Disparities  
 
Two key questions emerge: 
 
1. To what extent can prevention, early detection, treatment, and communication 
interventions effectively reduce cancer-related health disparities?  
2. How can we best measure and monitor cancer-related health disparities across the 
spectrum of cancer incidence, stage of disease at diagnosis, disease recurrence, quality of 
life, and cancer mortality?  
 
Over the past few decades, NCI has worked with other agencies to create a national cancer 
surveillance system for tracking cancer trends.  At the heart of this system is the monitoring of 
cancer incidence– the number of people per 100,000 who develop cancer in a given year - and 
cancer mortality− the number of people per 100,000 who die from cancer each year.  The system 
is also able to track cancers that may be declining or on the rise.  Because of cancer surveillance, 
for example, we know that since 1990, the rates of both new cancers and deaths have fallen for 
all cancers combined and for most of the top 10 cancers, reversing a decades-long trend of rising 
rates in the United States.  However, we are striving to build a surveillance system that not only 
tracks cancer statistics, but also helps us form hypotheses for cancer research, make critical 
scientific and public health decisions about this disease, develop prevention and control 
measures, and assess whether interventions are making a difference.  Recent rapid advances in 
computerized information technology, increasing diversity in the U.S. population, and changes in 
health care delivery present new challenges to building such a surveillance system.  For NCI to 
continue its pivotal role in effective and comprehensive national surveillance in a changing 
cultural, social, and technological milieu, we must respond on at least three fronts. 
 
First, we must improve surveillance activities on several levels.  We must create up-to-date 
statistical and analytical measures and improve the ways we apply the data.  NCI’s Surveillance, 
Epidemiology, and End Results (SEER) program must cover a broader spectrum of the 
population and compare information on why people get cancer and how it is treated with 
outcomes such as quality of life, and mortality.  We must improve the measures we use to track 
cancer risk, screening practices, treatment, quality of life, quality of care, and morbidity.  
Improved surveillance programs must also integrate measures related to physicians, health 
systems, cancer communities, and policy into local and regional databases.  We need to apply 
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to explain:
electronically to ensure the privacy and confidentiality of individuals.  New trend modeling 
techniques are needed to help us explain the trends across the cancer continuum.  Health-related 
geographic information systems are needed to examine regional cancer data on individuals in 
relation to potential environmental exposures. Cancer maps must be refined to allow easier 
application of statistical analyses that measure cancer patterns and identify cancer clusters. 
 
And third, we must enhance dissemination of surveillance data to scientists, the public, and 
policy makers.  Cancer surveillance data will have its greatest impact on reducing the cancer 
burden only if it is provided in a timely manner and in a readily usable format to those who need 
it. 
 
RESEARCH CAPACITY AND INFRASTRUCTURE: 
 
Training and career development for the next generation of scientists remains one of our most 
important challenges.  The scientists of the future will need to be more versatile in their use of 
new technologies, able to work in teams to understand the complicated environmental, lifestyle, 
genetic, and molecular variables contributing to human cancers, and better prepared to translate 
discoveries into public benefit.  We need to implement and sustain multiple long-term strategies 
to attract the most talented individuals to cancer research.  We need to create a stable cadre of 
well-trained technical, biological, behavioral, medical, and public health scientists dedicated to 
the cancer research enterprise.  And, as the interdisciplinary environment increasingly becomes a 
way of life for researchers, we need to ensure that scientists can and will work together 
effectively to solve problems.       
 
Our success will depend upon our ability to move beyond traditional educational and research 
cultures, overcome health financing constraints, and address socioeconomic inequities that have 
proven to be barriers to progress in the past.  The theme for the future is to train scientists to 
work on problems as integrated, multidisciplinary teams.  
 
To meet these challenges, we must continue to implement training and career development 
strategies to address a number of crucial issues.  We must: 
 
•  More adequately prepare basic scientists from all segments of the population and provide them   
with more attractive career paths.  By providing basic scientists in training with the  
background to conduct research directly related to human cancer and preparing them to  
collaborate with clinical and population scientists, NCI can provide them with the skills  
to be successful contributors to cancer research teams.  Moreover, increasing trainees’ 
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these comprehensive improvements to help the cancer community identify areas to target for 
research and for health policy and planning.  
Second, we must develop research tools that will allow us to track cancer trends more completely 
and more precisely.  We must improve the way we make cancer surveillance data available 
 
•  Reverse the migration of talented and creative physicians from research to  
practice.  This is the single most threatening consequence to cancer research from the 
shifting economics of the health care system.  We must use more effective means to train 
clinical investigators and ensure they have protected time to conduct the patient-oriented 
research that ultimately will translate basic discoveries into better methods for cancer 
prevention, diagnosis, and treatment.  These investigators must receive the necessary 
intensive training and education that guarantees informed consent and provides maximum 
safety for patients participating in research.  
 
•  Increase the numbers and stabilize the careers of cancer prevention, control,  
population, behavioral, and public health scientists from all segments of the population.  
The discoveries of scientists dedicated to prevention, early detection, behavior 
modification, and risk factor analysis will have a major impact on reducing future cancer 
incidence and mortality.  We must develop better ways to train these scientists to function 
in interdisciplinary research settings and work effectively with patient-oriented and basic 
scientists.  We also must provide these scientists with protected time in which to conduct 
research.  
 
•  Create a research community that is ethnically and racially diverse.  We need  
scientists who are particularly sensitive to the factors that lead to disproportionate cancer 
incidence and mortality in underserved populations and who are prepared to conduct 
research that will help overcome the cultural and socioeconomic barriers responsible for 
the unequal burden of cancer.  
 
•  Attract and integrate technical and informatics experts from all segments of the 
population into cancer research.  Specialists in these disciplines are likely to provide a 
critical driving force for future progress. 
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that careers in basic science will continue to remain attractive.
 stipends to levels more reflective of their education and skills will help ensure 
COMMUNITY OUTREACH, INFORMATION DISSEMINATION, PUBLIC HEALTH 
EDUCATION: 
 
NCI has designated Cancer Communications as an Extraordinary Opportunity for Investment.  
As is true for many other areas, activities related to communication to minority and underserved 
populations are intertwined with our efforts to communicate to all about cancer.  To maximize 
the effectiveness of all our communications and to support communications research, planning, 
implementation, and evaluation, we are taking steps to collect, more effectively analyze, and 
disseminate critical information about various audience groups.   
 
It is not unusual today for newly diagnosed cancer patients to go to their doctors’ appointments 
armed with printouts from CancerNet or other Web sites and lots of questions.  People have 
more ways than ever to get information: by telephone, fax, email, the World Wide Web, TV, 
radio, and in person.  And the future holds even more choices: automated monitoring of vital 
signs, voice recognition software, wider use of wireless technology, and other technologic 
advances to make it easier and faster for people anywhere to get access to the best information 
about cancer.   
 
NCI’s opportunity is to optimize the use of these tools while enhancing the absolutely essential 
interaction of patients with their doctors and nurses.  Indeed, new communication tools can 
facilitate partnerships between patients and their physicians.  We must push forward the frontiers 
of technology in support of the public, patients, their families, and medical teams to ensure 
access to individualized, high quality, NCI-validated information.  From primary prevention to 
survivorship and end of life issues, communication empowers people to make informed cancer-
related decisions and to engage in behaviors that will improve their health.   
 
To build on our progress in refining health communication theories and interventions, we must 
close major gaps in our understanding of how people access and use health information as well 
as the gaps between what is known and what is practiced.  We must:  
 
•  Provide accurate and balanced information about all areas of cancer prevention, 
diagnosis, treatment, and care, including complementary and alternative therapies to all.  
•  Learn how to help all people distinguish important health risks from insignificant ones   
and make informed choices despite exposure to contradictory or inaccurate health 
messages.  
•  Inform physicians, nurses, and other health care providers from all segments of  the  
population of emerging best practices, help them become more effective communicators,  
and integrate cancer communications into all aspects of cancer care.  
•  Find and implement the best ways to disseminate research results to the cancer Research  
community, medical practitioners, patients, at-risk persons, and the public in all segments  
of the population. 
•  Increase patient access to and participation in high quality clinical trials to speed the pace   
of discovery.   
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•  Expand the cadre of health communications scientists and practitioners from all  
segments of the population who conduct research and apply results.  
 
 
Through these efforts, we will gain a far richer understanding of how people use health 
information and access communications technologies of all kinds.  We will use that 
understanding to improve outcomes in cancer prevention, early detection, and treatment, and 
improve the lives of cancer survivors and those patients receiving palliative care.  NCI is 
committed to reducing, and, ultimately, eliminating cancer-related health disparities, and we are 
just as convinced that health communications research and health communications activities are 
critical to meeting this goal. 
 
AREAS OF EMPHASIS 
 
In FY 2001, NCI’s National Cancer Advisory Board Ad Hoc Committee on Coding for Research 
on Minorities established definitive guidelines on how NCI should characterize the Institute’s 
research portfolio regarding ethnic/racial minority research, including the level of detail needed 
in the financial coding of minority research.   In compliance with these guidelines, the objectives 
listed in Appendix A, though vital to reducing cancer health disparities, are designed to benefit 
the broader cancer community but are vital to the comprehensiveness of this Strategic Plan.  
Similarly, Appendices B, C, and D describe ongoing projects that continue to have an impact on 
the reduction of disparities but are designed to benefit the broader cancer community.  
  
GOAL A:  RESEARCH  
 
Objective A.1:   Improve capacity and accelerate knowledge through fundamental cancer control 
and population research. 
 
Action Plan A.1:    
 
Establish Centers for Population Health and Cancer and expand epidemiological investigations to 
explore racial and ethnic cancer disparities with a focus on cancers for which these disparities are  
greatest (e.g., breast, cervix, kidney, prostate). Conduct new methodological studies to evaluate  
factors influencing recruitment and participation of underserved populations in cancer 
epidemiology studies. 
 
Timeline:  
FY 2002 - Concept review, Call for RFA applications;  
FY 2003 - Review applications, award grants, expand epi studies 
FY 2004 - Continue support   
FY 2005 - Continue support  
FY 2006 - Continue support  
 
 10
 
Performance Measures for A.1:    
 •  Advance understanding of the development and progression of disease. 
•  Develop new or improved approaches for preventing, or detecting, or diagnosing  
the onset or progression of disease and disability. 
•  Develop new or improved approaches for preventing or delaying the onset or  
progression of disease and disability. 
•  Develop new or improved approaches to treating disease and disability. 
•  Advance the understanding of the social and environmental determinants of  
cancer and the psychosocial, behavioral, and biologic factors that mediate them.    
•  Develop, apply, and evaluate interventions to improve cancer outcomes and  
reduce outcome disparities.   
•  Expand existing epidemiological studies and conduct new studies to evaluate  
factors influencing participation by specific populations in cancer epidemiological studies  
•  Disseminate health promotion and disease prevention interventions to the research  
and provider communities. 
 
Outcome Measures for A:1: 
  1. Evidence of expanded knowledge of fundamental cancer control through  
publications, presentations and awards for projects  that examine determinants of 
cancer health disparities. 
2. Number of new grants, contracts and intramural projects  for  fundamental cancer 
control and population research directed towards minority and underserved 
populations. 
3. Number of new grants, contracts and intramural projects to examine issues related 
to epidemiological studies with specific populations. 
4. Production of targeted evidence-based cancer control interventions included in the 
Guide to Community Preventive Services. 
 
Objective A:2   Expand cancer control intervention research in prevention, early detection, 
treatment, and communications. 
 
Action Plan A.2:    
  •  Enhance SPN sites research infrastructure and training in underserved  
communities.    Partner with academic cancer centers to continue developing and testing  
community based, participatory cancer control interventions addressing disparities. 
Provide additional funds for pilot cancer control research projects within SPNs.  
 •  Provide supplemental funding to Transdisciplinary Tobacco Use Research  
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Estimated Completion Date for Objective: ongoing (evaluate FY 2006)  
Centers (TURCs) to study differential tobacco use and quitting patterns among 
underserved populations and support development of more effective interventions to 
reduce the burdens associated with tobacco use.  
•  Expand colorectal cancer screening use and follow-up studies. Conduct new  
intervention research to identify and overcome sociocultural and health care system 
barriers to the continuing under-use of fecal occult blood testing and flexible 
sigmoidoscopy, and to address co-morbid illness and other barriers to appropriate clinical 
follow-up of abnormal findings.   
•  Expand research on breast and cervical cancer screening for women who have  
never been screened and those who are not screened regularly. Support new intervention 
research to identify barriers to screening for women who underuse or never use breast 
and cervical screening and address sociocultural determinants in planning, implementing, 
and evaluating these interventions. 
  
Timeline:
 FY 2002 - increase support for all actions; 
 FY 2003 - increase support for all actions; 
 FY 2004 - provide ongoing support and evaluate 
 FY 2005 - provide/increase support 
 FY 2006 - provide/increase support 
 
Estimated Completion Date for Objective: 2006 (expected to be ongoing) 
Performance Measures for A.2 : 
•  Increase number of grants awarded, partnerships developed with academic cancer  
centers that address barriers to access, and that address sociocultural determinants of 
cancer outcomes.  
•  Increase number of supplements provided to Transdisciplinary Tobacco Use  
Research Centers (TTURCs) 
•  Increase in number of patients screened for colorectal cancer screening use and  
follow-up studies. 
•  Increase support for quality of care assessment with respect to unequal access. 
•  Establish  new and expanded collaborative arrangements with the Centers for  
Disease Control and Prevention to support new intervention research on barriers to 
screening for women for cancer disease. 
  
Outcome Measures for A.2: 
1. Number of grants awarded, partnerships developed with academic cancer centers 
that address barriers to access, and that address sociocultural determinants of 
cancer outcomes.  
2. Number of supplements provided to Transdisciplinary Tobacco Use Research 
Centers (TTURCs). 
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3. Number of culturally and educationally appropriate cancer awareness campaigns 
focused on underserved populations. 
 
    Reduce outcome disparities in specific populations by increasing access to 
state-of-the-art clinical trials in cancer prevention and treatment.  
 
Objective A:3
Action Plan A:3 
 •           Expand Clinical Trials Outreach Programs to increase participation by  
underrepresented populations; establish clinical trials units at minority-serving medical 
institutions; strengthen clinical trials units at minority-based community oncology sites. 
•  Increase clinical trials participation by minority physicians and health  
professionals by implementing an NCI fellowship training program in clinical trials for 
minority physicians and forums for minority scientists’ input into developing clinical 
trials that address issues of special importance for minority and special populations.  
•  Expand the radiation oncology-based Cancer Disparities Research Program,  
initiated in 2002, by funding 3 additional centers.  Use this program to expand  
clinical research infrastructure within communities with disproportionate cancer-related 
health disparities and examine novel approaches to more closely link these groups with 
cancer researchers.  
 
 
Timeline: 
 FY 2002 -increase support for all actions 
 FY 2003 -increase support for all actions 
 FY 2004 - provide ongoing support and evaluate 
 FY 2005 -provide/increase support 
 FY 2006 -provide/increase support 
 
Estimated Completion Date for Objective: 2006 (expected to be ongoing) 
 
Performance Measures for A.3: 
 •  Continue support for the Minority-based Community Clinical Oncology Program  
which   addresses the clinical research questions relevant to the disproportionate cancer 
burden experienced by specific populations. 
•  Establish collaborations with key minority professional organizations to increase 
  participation of physicians from underserved populations in cancer treatment and  
  prevention trials. 
•  Increase number of constituent contacts with specific population members made  
by the   NIC’s Office of Liaison Activities to ensure that the Institute is aware of  
and responsive to cancer-related issues affecting specific populations groups. 
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Outcome Measures for A.3: 
 1. Increased number of institutions participating in the Minority-based Community Clinical 
Oncology Program. 
2. Increased and sustained number of collaborations with key minority professional 
organizations. 
3. Increased number of minority and underserved patients participating with cancer 
prevention and treatment trials. 
4. Increased number of minority physicians and health care providers participating in cancer 
prevention and treatment trials. 
5. Development of culturally appropriate patient education materials. 
6. Development of clinical trials data management infrastructure. 
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GOAL B:  RESEARCH CAPACITY AND INFRASTRUCTURE  
 
Objective B.1:  Expand programs to recruit, train, and sustain underserved racial and ethnic 
minority individuals in cancer research and provide partnership opportunities for training and 
career development. 
 Action Plan B.1: 
  •  Expand the Continuing Umbrella of Research Experiences (CURE) Program by:  
increasing the number of trainee positions on institutional NSRAs by 50; providing new 
supplemental funding to 10 cancer centers for high school and undergraduate student 
research experience; funding 10 new minority training positions in Clinical Oncology 
Career Development Programs; funding 10 new positions for Cancer Education and 
Career Development Programs in the population sciences; funding 50 new Minority 
Investigator Supplements to NCI research project grants; funding 20 new mentored 
career development awards for basic scientists and clinically trained scientists; and 
funding 10 new Career Transition Awards for basic, clinical, behavioral, and population 
minority scientists in their first junior faculty positions. 
•  Promote collaborations between scientists and educators in MSIs and in NCI- 
designated Cancer Centers through 15 planning grants for developing MSI/Cancer Center 
research training programs for minorities and outreach education programs for minority 
communities. 
•  Increase minority access to training and career development opportunities by  
improving NCI Internet information services, establishing linkages between public and 
private agencies that provide related services, and establishing 20 new positions in NCI 
Cancer Centers that will “broker” the connections between minority individuals seeking 
research experiences and Cancer Center scientists. 
•  Integrate the NCI CURE Program and the NCI Minority Institution/Cancer Center 
Partnership Program more effectively into the Minority Biomedical Support Grant 
Program in the National Institute of General Medical Sciences. 
 
 
Timeline:
 
 
 FY 2002 -increase support for all actions 
 FY 2003 -increase support for all actions 
 FY 2004 - provide ongoing support and evaluate 
 FY 2005 -provide/increase support 
 FY 2006 -provide/increase support 
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Estimated Completion Date for Objective: FY 2006 (expected to be ongoing) 
Performance Measures for B.1: 
 •  Fund five additional trainees in the NCI Scholars Program and  create two new  
intramural training and career development programs. 
•  Expand the number of well-trained basic research and in patient-oriented research 
scientists who are members of specific populations. 
•  Expand the number of well-trained population, behavioral, and public health  
scientists in cancer research who are members of specific populations. 
•  Examine Career advancements made by graduates of the National Research  
Service Award (NRSA). 
•  Continue support for the Minority Institution/Cancer Center Partnership (MICCP) 
Program by funding comprehensive partnerships, planning grants for comprehensive 
partnerships, and planning grants for more focused collaborative programs.  
 
Outcome Measures for B.1: 
 1. Number of participants and graduates of the NCI Scholars Program. 
2. Number of participants and graduates of the Intramural training and career development 
program. 
3. Number of new individual mentored awards, transition awards for junior independent 
scientists, and  awards to established investigators. 
4. Number of participants and graduates of the National Research Service Award (NRSA). 
5. Number and projects of the Cancer Prevention Fellowship Program participants. 
6. Number of individual and institutional training and career development awards to 
minority members or scientists focusing on areas of cancer health disparities. 
7. Increase in the individual mentored 5-year awards to provide special opportunities for 
M.D.s in basic or clinical research and for individuals pursuing cancer prevention, 
control, behavioral, and population science in areas of cancer health disparities. 
8. Increased number of Bridging awards that encourage basic scientists and minority 
scientists to pursue careers in cancer research.  These require recipients to undertake 
mentored and independent research, providing them time to develop independent 
research programs. 
9. Increase number of Transition awards that provide 3 years of protected time following 
mentored postdoctoral training or for new investigators to initiate successful research 
programs, especially for minority scientists. 
 
Objective B.2: Strengthen training and education in health disparities research so as to expand 
minority investigator competition for and minority population involvement in health disparities 
research. 
Action Plan B.2: 
 •  Develop a new track in the Cancer Prevention Fellowship Program to increase the 
number of scientists studying health disparities. Recruit 2 fellows per year to focus on 
health disparities research within CRCHD and the Division of Cancer Control and 
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Population Sciences. 
 •  Expand community-based, cancer control research training within underserved  
communities. Encourage cancer centers to partner with community organizations and 
health care institutions in underserved areas to apply for training grant support for 
community-based clinical and cancer control research training in health disparities 
research. 
•  Expand programs to recruit, train, and sustain underserved racial and ethnic 
minority individuals in disparities research by providing opportunities for these activities 
in the context of interactions between Minority-Serving Institutions and NCI Cancer 
Centers. 
 
 
Timeline:  
 FY 2002 -  Increase funding: Instit.Clinical Oncology Center Development Programs   
FY 2003 - Continue funding 
FY 2004 - Continue funding  
FY 2005 - Continue funding  
FY 2006 - Continue funding  
 
Estimated Completion Date for Objective: ongoing programs - evaluate in FY 2006 
 
Performance Measures for B.2: 
•  Increase the number of participants in the Cancer Centers Program which will  
 bring together diverse scientific disciplines across institutional boundaries. 
• Funding of Established Investigator Awards that provide seasoned investigators in  
the clinical sciences and in cancer prevention, control, behavioral, and population science 
protected time to conduct research and mentor new scientists. 
•  Create new Diversified Science Career Development awards to attract technology 
developers and scientists in disciplines not traditionally associated with cancer research 
but clearly needed in the future. 
•  Continue support for the Institutional Education and Career Development  
Programs, initiated in 2000, to prepare participants for collaborative, multidisciplinary 
team research settings. 
 
 
Outcome Measures for B.2: 
 1. Number of minority scientists supported by the CMBP. 
2. Increased number of Established Investigator Awards. 
3. Increased number of Diversified Science Career Development Awards. 
4. Increased number of Institutional Education and Career Development Programs 
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Action Plan B.3: 
•  Establish formal affiliations between Cancer Centers and Minority-Serving  
Institutions (MSIs) in the form of 2 comprehensive partnerships and 1 planning grant for 
a comprehensive partnership to enhance the research capabilities of MSIs, and improve 
the effectiveness of Cancer Centers in serving minority communities. 
•  Provide supplemental funding to existing and new Cancer Centers for health  
disparities research, to reduce the heaviest cancer burdens among disadvantaged 
populations, address disparities in risk factors, access to prevention interventions (e.g. 
smoking cessation, dietary change, physical activity), quality cancer care, and clinical 
trials.  
•  Provide supplements to investigators and cancer centers to expand research on  
disparities in survivorship, including ethnic, cultural, socioeconomic, and institutional 
factors affecting the quality and length of cancer survivorship in underserved 
communities and strategies to help cancer patients and their families make the transition 
to extended and long-term survivorship 
•  Provide up to 3 years of supplemental funding to cancer centers to stimulate 
Disparity research, particularly those located in or near underserved communities that 
experience the heaviest burden of cancer. High priority areas will include disparities in 
risk factor exposures and access to prevention interventions (e.g., smoking cessation, 
dietary change, and physical activity), quality cancer care, and clinical trials. 
Timeline: 
 FY 2002 -  Increase funding; develop and support partnerships 
FY 2003 -  Increase funding; support partnerships 
FY 2004 -  Increase funding; support partnerships 
FY 2005 -  Increase funding; support partnerships 
FY 2006 -  Increase funding; support partnerships 
 
Estimated Completion Date for Objective: ongoing   
 
Performance Measures for B.3: 
•  Number of new and expanded affiliations established between the Cancer Centers  
and Minority-Serving institutions 
•  Number of supplementals to support existing Cancer Centers conducting research  
investigations on health disparities in underserved populations 
•  Number of supplementals to support investigators and Centers to expand research  
on health disparities in survivorship in underserved populations. 
 
 
Outcome Measures for B.3: 
1.         Number of new grant applications submitted and number funded as the  
                              result of programmatic efforts. 
2.                     2.         Number of continuing competing grant applications submitted and funded. 
3.                     3.         Number of investigators and Centers receiving supplemental funds. 
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Objective B.3: Create partnerships between Minority-Serving Institutions and NCI Cancer 
Centers. 
GOAL C: PUBLIC INFORMATION, OUTREACH, AND EDUCATION  
 
Objective C.1:  Increase access to and use of cancer communications by all populations, 
especially underserved populations.  
 
Action Plan C.1: 
•  Analyze and disseminate results of four Digital Divide Pilot Projects to test  
strategies to increase access to and use of online and other interactive cancer 
communications by underserved populations. 
•  Fund additional Digital Divide Pilot Projects and evaluate outcomes. 
•  Transform the clinical trials Web portal to enable visitors to more quickly find 
information and resources. 
•  Build special education/dissemination and diffusion partnership programs to reach 
underserved communities, test these programs’ value in reducing health disparities in 
underserved communities, and make successful pilot programs available for use by local, 
regional, and national organizations concerned with cancer and public health. 
•  Provide one-year competitive supplements to investigator-initiated intervention  
research grants. Create a supplemental funding mechanism to develop and implement a 
dissemination and diffusion plan for interventions proven by the original intervention 
research to be effective in reducing health disparities. 
•  Fund supplements to NCI research grants for dissemination of evidence-based 
interventions specifically aimed at reducing health disparities. 
•  Expand support for advanced training of state health department staff and 
American Cancer Society volunteers in best practices for using surveillance and 
intervention evidence data in comprehensive cancer control planning.  
•  Establish and maintain local and regional partnerships to understand and  
overcome cancer control infrastructure barriers that contribute to health disparities.   
•  Establish new comprehensive cancer control program initiative with the 
Washington, D.C. Department of Health. 
•  Develop and demonstrate approaches for bringing the latest interventions in  
cancer screening, care, and treatment, including access to clinical trials, to Native 
American populations through national and regional Indian health boards, tribal 
organizations, the Indian Health Service, and established Native American investigators.  
 
Timeline: 
FY 2002 -  expand support; establish and strengthen partnerships and collaborations  
FY 2003 -  expand support; establish and strengthen partnerships and collaborations  
FY 2004 -  continue support; evaluate effectiveness; review funding levels  
FY 2005 -  continue support; reevaluate level of support  
FY 2006 -  continue support; strengthen partnerships and collaborations  
 
 
Estimated Completion Date for Objective : ongoing; Evaluate in FY 2006  
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instruments and new databases to increase access by all populations to cancer information 
across the digital divide. 
•  Number of  survey and data instruments based on diverse population groups  
developed and disseminated to program planners and researchers 
•  Increased support to operate the NCI’s database to facilitate planning and  
evaluation of use of new media and to facilitate communication among researches and 
planners. 
 
Outcome Measures for C.1 : 
•  Number of research projects submitted and funded to develop survey instruments  
•  Number of hits on the Web site by planners, programmers who interrogate the 
databases and the categories of information extracted. 
•  Number of new supplements funded for research on dissemination of evidence- 
based interventions aimed at reducing health disparities. 
 
Objective C.2:  Develop a menu of communication choices to meet the needs of all users, and 
especially to increase knowledge about, tools for, access to, and use of these choices by diverse 
populations. 
 
Action Plan C.2: 
•  Develop new tools and products to facilitate cancer communications for the  
public, patients and their caregivers, underserved populations, advocacy groups, health 
professionals, and cancer communicators. 
•  Continue work with Agency for Healthcare Research and Quality to fund research  
on decision aids (“Making Quality Count for Consumers and Patients”).  Link with 
Digital Divide Pilot Projects to promote dissemination and use of interactive 
communication tools, and collect information on current levels of, and barriers to, use. 
•  Assess the status of low-literacy research and national initiatives in order to  
develop a strategic plan for low-literacy programs and materials. 
•  Develop and promote a media toolkit to facilitate the media’s use of NCI’s  
resources in preparing cancer-related stories. 
 
 
Timeline: 
FY 2002 -  Expand support 
FY 2003 -  Expand support 
FY 2004 -  Expand support 
FY 2005 -  Expand support; begin evaluation process  
FY 2006 -  Expand support 
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Performance Measures for C.1:
•  Number of meetings/workshops convened directed to developing survey  
 
Performance Measures for C.2: 
•  Convene workshops/meetings to assess the needs and type of communications 
tools needed for populations with low literacy. 
•  Convene workshops/meetings to develop an interactive system of narratives to  
convey clearly cancer-related stories and identify methods for effective dissemination 
 
Outcome Measures for C.2: 
1. Number of Request for Applications (RFAs) and Program Announcements (PAs) 
to further characterize approaches to communicate  low-literacy research and 
national initiatives in order to develop a strategic plan for low-literacy programs 
and materials. 
2. Number of communities with demonstrated benefits from the studies as measured 
by survey instruments and other forms of information gathering techniques. 
 
 
 SUMMARY AND PERSPECTIVES 
 
In this document, an ambitious plan is described that has as its overarching purpose to reduce 
and eventually eliminate cancer-related health disparities.  As the largest of the NIH’s institutes, 
the NCI has a very diverse portfolio of ongoing and anticipated activities in this area.  Many of 
the programs, activities, and individual initiatives that comprise our efforts to reduce disparities 
in cancer address more than one aspect of the challenge.  An attempt has been made to describe 
these activities in the context of the three-pronged goals of the NIH in this area, namely 
Research, Research Infrastructure, and Public Information, Outreach, & Education.  NCI has 
ongoing activities in all three areas, and we also will be expanding ongoing activities and 
creating new activities in all three areas.  
 
Our ultimate hope is that there will come a day when it will no longer be necessary to invest in 
reducing cancer health disparities because they will be eliminated.  Until that day arrives, the 
NCI will remain committed to the cause. 
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Estimated Completion Date for Objective: ongoing 
 
 
APENDIX A: 
Overarching  Objectives that Impact on Issues of the  Broader Cancer Community, 
including the  Reduction of Cancer Health Disparities 
 
Research 
•           Fund additional research based on expansion of prior studies,e.g. the Prostate
            Cancer Outcomes Study, to examine risk factors associated with late-stage disease - 
            lifestyle, biological and clinical characteristics, and access to care - while accounting for 
            state-of-the-art measures of socioecononmic status. 
 
•  Collaborate with DHHS task force to contribute to the training of state health  
department staff and volunteers from 17 divisions of the American Cancer Society (ACS) 
in best practices for using data to improve cancer control planning, collaboration with 
ACS and the Center for Disease Control and Prevention (CDC). 
 
•  Continue having the CRCHD address excess cervical cancer mortality throughout  
the nation through “Think Tanks” and focused interventions. 
 
•  Convene of “Think Tanks” by the CRCHD to address the racialization of society  
and its effect on cancer health disparities. 
 
•  Support research on the biologic variability in cancer in terms of tumor  
aggressiveness, differential response to therapy, genetic polymorphism, and 
psychoneuroimmunologic factors as mediators of social environment. 
 
•  Build on findings from the Prostate Cancer Outcomes Study to examine risk  
factors associated with late-stage disease - lifestyle, biological and clinical characteristics, 
and access to care - while accounting for state-of-the-art measures of socioeconomic 
status. 
 
•  Expand systems and methods to enhance the quality of cancer control data on  
risk, health and behaviors, and screening practices linked to high quality data on  
cancer outcomes.  
 
•  Continue the Current Population Survey (CPS) Tobacco Use Supplements, with 
the 2003 survey focusing on key tobacco cessation issues, and extend support for analytic 
tools, resources, and investigator-initiated research to use a decade of CPS Tobacco Use 
Supplements for evaluating local, regional, and national progress in tobacco control. 
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•   Support development of a restricted access research data center required for  
linked databases containing potentially identifiable information. 
 
•  In collaboration with the Agency for Healthcare Research and Quality, develop a  
surveillance and behavioral colorectal cancer screening initiative to improve compliance 
with screening and monitor performance in primary care practices. 
 
•  Explore data systems to monitor the use and side effects of spiral-computed  
tomography for lung cancer and the role of Pap smears versus Human Papilloma Virus 
testing for cervical cancer screening. 
 
•  Expand the Cancer Research Network as a population laboratory for evaluating  
progress in cancer control and care within integrated health care delivery systems. 
 
•  Collaborate with private and public partners to facilitate transition phase of  
obtaining cancer stage and care data in 2003 that is not currently part of routine cancer 
registration. 
 
•  Update linked databases for tracking cancer care, such as the linked SEER- 
Medicare database, and develop new linked databases related to cancer control and 
treatment at the population level for people under age 65. 
 
•  Use statistical and methodological research to improve the accuracy and  
reliability of cancer- relevant measures -- including self-report and biological diet 
measures, physical activity, and social and psychological behavioral determinants for use 
in surveillance and epidemiological research. 
 
•  Develop statistical and graphical methods, software applications, and other  
technologies relevant to geospatial and mapping research. 
 
•  Expand systems and methods to enhance capacity for exploring causes of cancer,   
generating new hypotheses on risk, and identifying new opportunities for cancer control 
interventions. 
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•  Enhance national and regional data systems to improve measurement of key  
issues for cancer trends and data on socioeconomic and other demographic measures.  
Initiate data tracking systems for cancer control and treatment drugs and for over-the-
counter prescription drugs and complementary and alternative therapies. 
 
graphic software for visualizing disease patterns and advancing use of disease-exposure 
GIS applications.  
 
•  Support workshops and pilot study on enhancing surveillance systems for 
research in gene-environment interactions and identifying the potential for cancer control 
interventions at the population level. 
 
•  Increase the number and broaden the geographic distribution of NCI-designated  
Cancer Centers by awarding new Cancer Centers in geographic areas not presently 
covered.   
 
•  Provide supplemental funding to existing and new Cancer Centers for health   
disparities research, to reduce the heaviest cancer burdens among disadvantaged 
populations, address disparities in risk factors, access to prevention interventions (e.g. 
smoking cessation, dietary change, physical activity), quality cancer care, and clinical 
trials. 
 
Research Capacity And Infrastructure 
 
Improve cancer registry data by expanding Surveillance, Epidemiology, and End Results (SEER)   
coverage, improving the quality of all population-based cancer registries, and enhancing SEER as 
a research resource. 
 
•  Support 2 to 5 new SEER registries to improve coverage of key populations: non- 
Mexican Hispanics, residents of Appalachia and other rural areas (especially those of 
lower socioeconomic classes), rural African Americans, American Indians, and 
populations with high cancer mortality rates.  
 
•  Enhance national and regional data systems to measure disparities in cancer-related health  
behaviors and screening practices. Expand support for supplements to national and 
regional surveys to enhance data on socioeconomic and other demo-graphic factors  
associated with disparate cancer outcomes.  
 
•  Support statistical and methodological studies to improve accuracy and reliability of data    
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•  Provide critical tools for cancer control, especially at the community level, by  
developing a Web-based Internet lecture series on use of Geographical Information 
Systems (GIS) and other data sources for cancer control research; working with the 
National Science Foundation on use of geographical data; and developing analytic and 
•  Encourage use of NCI Atlas of Cancer Mortality in the United States, 1950-1994, 
and other population-based data systems (e.g. Long Island Breast Cancer Study), as a 
source of study from high-risk areas. 
 
 
 
on socioeconomic determinants of cancer rates and risk, health behaviors, and screening
different age, race-ethnicity, and socioeconomic groups as a measure of quality of care in 
situations where there is uncertainty about the efficacy of interventions. 
 
•  Conduct methodological evidence-based research to ensure that survey, epidemiological, 
and clinical research involving cancer risk factors exhibits cross-cultural equivalence.  
 
 •  Enhance use of the NCI Cancer Progress Report process to monitor health disparity  
reductions and reach Healthy People 2010 goals. 
 
•  Refine and harmonize federal cancer registry programs (i.e. four new expansion registries  
added to SEER to improve coverage of key populations) to meet SEER standards for data 
quality, and use the data for reporting and for cancer control activities.
  
 •  Identify registry operations that will help meet SEER standards by implementing and  
                        improving quality assurance procedures and use of data quality profiles.
                                    •  Improve coordinated federal cancer registry programs through development of enhanced
                                                            information technology systems for registry operations in SEER programs. 
 
•  Support innovative statistical survey research methodology and complex regression   
models for combining data from diverse sources to meet the needs of the evolving 
 national cancer surveillance data. 
 
            Expand systems and methods to enhance the quality of cancer control data on risk, health and 
behaviors, and screening practices linked to high quality data on cancer outcomes.  
 
•  In collaboration with the Agency for Healthcare Research and Quality, develop a  
surveillance and behavioral colorectal cancer screening initiative to improve compliance 
with screening and monitor performance in primary care practices. 
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in national and regional populations. Expand use of modeling and geographic analyses to 
examine the unequal burden of cancer. 
 •  Develop new data collection methods for socioeconomic and cultural factors including   
measures, data sources, and data linkage. 
 
•  Examine informed consent provided with prostate cancer screening and treatment in  
database, and develop new linked databases related to cancer control and treatment at the  
population level for people under age 65. 
 
•  Use statistical and methodological research to improve the accuracy and reliability of  
cancer- relevant measures -- including self-report and biological diet  measures, physical 
activity, and social and psychological behavioral determinants for use in surveillance 
and epidemiological research. 
 
•  Develop statistical and graphical methods, software applications, and other technologies   
relevant to geospatial and mapping research. 
 
•  Expand systems and methods to enhance capacity for exploring causes of cancer, 
generating new hypotheses on risk, and identifying new opportunities for cancer control 
interventions. 
 
•  Encourage use of NCI Atlas of Cancer Mortality in the United States, 1950-1994, and  
other population-based data systems (e.g. Long Island Breast Cancer Study), as a source 
of study from high-risk areas. 
 
•  Provide critical tools for cancer control, especially at the community level, by developing   
a Web-based Internet lecture series on use of Geographical Information Systems (GIS) 
and other data sources for cancer control research; working with the National Science  
Foundation on use of geographical data; and developing analytic and graphic software for  
visualizing disease patterns and advancing use of disease-exposure GIS applications. 
  
 •  Support workshops and pilot study on enhancing surveillance systems for research in  
gene-environment interactions and identifying the potential for cancer control 
interventions at the population level. 
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•  Expand the Cancer Research Network as a population laboratory for evaluating progress  
in cancer control and care within integrated health care delivery systems. 
 
•  Collaborate with private and public partners to facilitate transition phase of obtaining  
cancer stage and care data in 2003 that is not currently part of routine cancer registration.
 
 •  Update linked databases for tracking cancer care, such as the linked SEER-Medicare  
•  Explore data systems to monitor the use and side effects of spiral-computed tomography   
for lung cancer and the role of Pap smears versus Human Papilloma Virus testing for  
cervical cancer screening. 
 
cancer progress, including new measures and a 2003 feature on dissemination of 
cancer treatment advances. 
 
•  Support a Surveillance Evidence Review on cancers with adverse trends to evaluate  
research on epidemiological, surveillance, and treatment factors influencing trends, and 
collaboratively apply the data to develop focused health policy and plans to improve 
trends.  (Note: the Surveillance Evidence Review on cervical cancer in underserved 
populations is underway) 
 
•  Fund existing surveillance and applied research networks and consortia to conduct 
intensive training programs, provide sabbatical opportunities for research professionals, 
and initiate and develop academic curricula on surveillance, health services, and applied 
research. 
 
Establish new data collection and analysis strategies to support cancer communications planning 
and evaluation.  
 
•  Analyze data from the Health Information National Trends Survey (HINTS) and make   
results available to researchers and program planners as early as possible. 
 
•  Explore the use of Internet-based data collection to follow a subset of people interviewed   
as part of HINTS.  
 
•  Conduct a HINTS survey of cancer survivors in parallel with the HINTS public survey.   
The HINTS-S, or HINTS survivors survey, will collect data on survivors’ use of different 
media, their risk perceptions, cancer-related behaviors, personal cancer experiences, and 
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Increase the number and broaden the geographic distribution of NCI-designated Cancer Centers. 
Public Information/Outreach/Education 
 
Improve dissemination of information on cancer trends and progress in cancer control and care to 
researchers, public health professionals, the public, policymakers, advocates, and legislators.  
Enhance training opportunities in surveillance, health services. 
 
•  Continue public and private collaboration to expand local and national surveillance data   
dissemination for research and health policy planning, applying information technology to 
enhance visual quality, user interaction, and clarity for a diverse audience.
 
 •  Continue the NCI Cancer Progress Report as a vehicle for disseminating summaries of  
•  laboratories to develop and conduct training programs for researchers in growing areas,  
including risk communications and interactive health communications. 
 
•  Fund dissemination and diffusion supplements to grantees with proven interventions 
ready for dissemination.  These supplements would allow planning and piloting of 
dissemination with a focus on minority and underserved populations. 
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•  Explore the need for national data collection about health professionals’ communication   
practices. 
 
•  Continue to operate the NewMediacy listserv and health and lifestyle database to inform    
NCI’s planning and evaluation efforts about which audiences use which new media, and  
how they use them. 
  •  Create a searchable database of cancer-related communication research reports  accessible 
to researchers and program planners. 
 
Accelerate the pace of research and development of interventions in cancer communications. 
 
•  Continue to support Centers of Excellence in Cancer Communications Research. 
 
•  Establish interdisciplinary training partnerships and fund health communications  
use of complementary and alternative medicine.  We will assure adequate representation 
of diverse population groups. 
 
APPENDIX B: 
Selected Ongoing Research Activities related to the Reduction of Cancer Health 
Disparities  
 
CRCHD has initiated a series of discussions with the National Human Genome Research 
Institute (NHGRI) on health disparities and plans to develop collaborative programs on how best 
to use the tools developed by the Institute to address genetic bases for cancers in different 
populations and how environmental factors contribute to the development, progression, and 
outcome of cancers in these populations. 
 
Although cervical cancer mortality rates have diminished for the U.S. population as a whole, 
some geographic areas still have high death rates from this disease though it is relatively easy to 
detect and treat.  Under the leadership of CRCHD, NCI is reassessing the mortality rates for 
cervical cancer in different populations using SEER and other national databases to identify 
geographic regions of greatest mortality for disease.  It is expected that with closer examination 
of these mortality “hot spots” further discoveries about the populations effected and their 
environment are expected to lead to improved delivery of patient care.  
 
Within CRCHD,  NCI’s Special Populations Networks for Cancer Awareness Research and 
Training (SPN) are networks of 18 institutions that build relationships with community-based 
programs to foster cancer awareness activities, increase minority enrollment in clinical trials, and 
develop minority junior biomedical researchers through cancer control, prevention, research, and 
training programs in minority and underserved communities.  In the first year of this program, 
each SPN has (1) developed new culturally and educationally appropriate cancer awareness 
campaigns focused on African American, Asian American, Pacific Islander, Latin American, 
Native American, and low-income Appalachian white populations and (2) built collaborative, 
community-based infrastructures for cancer control research.  Also, many of the SPNs have 
worked to increase the competitiveness of junior and minority investigator-initiated research 
applications submitted for peer review by participating in three rounds of the developmental 
research grants program sponsored by NCI.   
 
NCI is focusing increased attention on how best to translate research into improved outcomes for 
all populations.  NCI leadership helped organize the Department of Health and Human Services 
(DHHS) task force on the dissemination of health promotion and disease prevention 
interventions.  The Institute has contributed to the training of state health department staff and 
volunteers from 17 divisions of the American Cancer Society (ACS) in best practices for using 
data to improve cancer control planning, collaboration with ACS and the Centers for Disease 
Control and Prevention (CDC).  The Institute has worked with the CDC to develop a targeted 
dissemination plan for evidence-based cancer control interventions to be included in the Guide to 
Community Preventive Services. 
 
 
 29
NCI has worked with the Agency for Healthcare Research and Quality and CDC to promote the 
adoption of best practices for clinical and public health approaches to tobacco control.  The 
Institute is working with the ACS and NCI-funded researchers to disseminate a dietary
intervention through faith-based organizations, tested with the NCI 5-A-Day research grant 
support, and found to be effective in two studies conducted among six African American 
churches in North Carolina and Georgia.  Working with ACS regional and African American 
church volunteers, NCI is supporting dissemination research of a unified Body and Soul program 
in nine matched pairs of African American churches in three regions, and ACS will provide 
sustained support for the intervention. 
 
NCI’s SEER cancer registry program has been expanded to cover more of the racial, ethnic, and 
socioeconomic diversity of the United States, allowing for better description and tracking of 
trends in health disparities. Methodological studies are seeking better ways to measure 
socioeconomic factors and determine their relationship to cancer incidence, survival, and 
mortality. In addition, NCI supports a growing body of research to examine the environmental, 
sociocultural, behavioral, and genetic causes of cancer in different populations and apply these 
discoveries through interventions in clinical and community settings. These interventions cover 
topics such as tobacco control, dietary modification, and adherence to screening practices. 
Recognizing the broad relevance of this research to other disease outcomes, NCI collaborates 
with other Federal agencies in supporting important research initiatives, including co-funded 
research with the Agency for Healthcare Research and Quality (AHRQ) under its initiative, 
“Understanding and Eliminating Minority Health Disparities.” 
 
We have expanded and improved the efficiency and utility of SEER on several fronts.  Four new 
SEER registries have expanded coverage of rural Whites and Blacks, non-Mexican Hispanics, 
American Indians, and states with high poverty and/or cancer death rates.  Collaborative ventures 
with the Centers for Disease Control and Prevention (CDC) and other registries coordinate 
collection and use of national and state cancer data.  Simpler, standardized rules for data 
collection create consistency among U.S. population-based cancer registries.  
 
We have expanded data on risk, health behaviors, and screening at the state and local level.  We 
have collected nationwide tobacco tracking data and conducted an in-depth evaluation, through 
the Cancer Research Network, of tobacco control delivered within medical practices across the 
United States.   
 
We have enhanced the dietary data collected in the National Nutritional and Health Examination 
Surveys by the National Center for Health Statistics in order to improve tracking of progress 
made towards achieving the Healthy People 2010 nutrition objectives relevant to cancer control.   
 
The 2000 National Health Interview Survey Cancer Control Topical Module - a survey of cancer 
risk, health behaviors, and screening conducted in collaboration with the National Center for 
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Health Statistics was released in the fall of 2001.  This survey provides data for tracking progress
in cancer control health practices, genetic testing issues, and other cancer-related health 
objectives.
 
We have used survey data to assess how community physicians use new knowledge about cancer 
risk, screening, and treatment.  A completed national Survey of Colorectal Cancer Screening
Practices in Health Care among 2,212 physicians helps identify potential targets for improving  
compliance with recommended screening.  A national Physician Survey on Cancer Susceptibility 
Testing examined comfort with and use of genetic susceptibility testing among 1,250 physicians. 
 
NCI has expanded research on the adoption of new advances in cancer treatment and how their 
use affects quality of life and patient-centered outcomes.  We have evaluated the diffusion into 
the cancer community of new cancer treatment advances; especially those highlighted by 
successful clinical trials, the NIH Consensus Development Conference reports, and NCI clinical 
alerts.  For example, patterns of care studies are drawing from a rich abundance of existing SEER  
registry data to quantify adoption of recommended treatments for breast and colon cancer.  These 
ongoing studies and the Cancer Care Outcomes Research and Surveillance Consortium 
(CANCORS) are expected to provide the basis to evaluate cancer treatments, quality of care, and 
their effect on quality of life and other patient-centered outcomes.  We have supported projects 
focused on the economics of cancer and on using claims data for evaluation of cancer health 
services.   
 
We also have expanded our research among cancer survivors, examining lifestyle and quality of 
life in relation to cancer treatment and survival.  For example a seminal workshop co-sponsored 
by public and private cancer organizations examined the role of physical activity across the 
cancer continuum.  An NCI-funded study - Health, Eating, Activity, and Lifestyle and Breast 
Cancer Prognosis - examined these factors among ethnically diverse community-based breast 
cancer survivors. 
 
We have been linking data on risk, screening, and treatment to outcomes.  An 
NCI/CDC/California State Department of Public Health venture, the California Health Interview 
Survey, provides a rich assessment of social, cultural, health system, and policy measures critical 
to local cancer control policy and planning in the diverse population of California.  We also have 
linked mammographic screening data in diverse communities to cancer outcomes in the NCI-
supported Breast Cancer Surveillance Consortium in order to provide national measures of 
mammography performance.   
 
To better track emerging trends in cancer and apply the data to reduce the national cancer burden, 
we have been providing new tools for exploring patterns and generating hypotheses for etiologic 
research, which examines the causes behind cancer cases.  
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•  Cancer Profiles, a system for identifying geographic areas in greatest need of cancer  
control activities, is being constructed in collaboration with CDC and other partners.  The  
Web-based interactive design will allow users to identify regions that match user-
specified statistical and trend comparison criteria.  The system will provide high quality 
data on ecological measures, such as demographic, socioeconomic, and other such 
measures that relate the effects of physical and social environments to cancer trends.   
Ecological measures are valuable for planning cancer control strategies.  This system will 
use advanced statistical methods to pinpoint the cancers that contribute most to recent 
state and national trends.  
 
•  Analytic tool kits developed by NCI, such as SEER Stat and associated statistical  
modules, facilitate the use of SEER and other cancer surveillance databases.  
Enhancements include ease of use, innovative new statistical measures, and 
improvements to existing measures and statistical modules.  Development of database 
management systems for SEER is making registry operations more efficient and 
promoting uniform standards and consistency of implementation. 
 
 
In summary, it is NCI’s goal to build a stable, racially and ethnically diverse cadre of basic, 
clinical, behavioral, and population scientists trained to work together effectively and to use the 
most advanced technologies in building our knowledge base and in translating discoveries into 
more effective cancer prevention, detection, diagnosis, and treatment strategies.  
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•  The Geographic Information Systems (GIS) for cancer control is an analytical tool that  
complements the Atlas of Cancer Mortality in the United States.  While the Atlas of
 Cancer Mortality in the United States shows geographic patterns of cancer death rates and  
makes it easy to uncover cancer patterns, Geographic Information Systems (GIS) provide 
tools for exploring patterns and generating hypotheses for etiologic research.  Two major 
improvements have been made to this specialized GIS.  The first, the Geographic-Based 
Research in Cancer Control and Epidemiology, supports use of the Cancer Atlas, GIS and 
other innovative methodological research in geospatial statistical analysis.  Collaboration 
with the National Science Foundation Digital Government Initiative supports method 
development for better visualization of spatial data.  This effort will help both scientists 
and non-scientists to comprehend these data. 
APPENDIX C:  
Selected Ongoing Activities to Build Research Capacity and Infrastructure related to the 
Reduction of Cancer Health Disparities 
 
Greater participation of minority health professionals in clinical trials is essential to our efforts to 
explore research questions about cancer-related health disparities. The Minority-based 
Community Clinical Oncology Programs have for many years sought to address clinical research 
questions relevant to the disproportionate cancer burden experienced by specific populations. 
NCI also has established collaborations with key minority professional organizations to increase 
participation of physicians from underserved populations in cancer treatment and prevention 
trials.  
 
NCI has launched the Minority Institution/Cancer Center Partnership (MICCP) Program in Fiscal 
Year 2001 by funding two comprehensive partnerships, two planning grants for comprehensive 
partnerships, and 12 planning grants dedicated to more focused collaborative projects and 
programs ranging from research to training.  This program reaches out to the five major minority
institutions with medical schools, as well as to more than 300 smaller institutions dedicated to 
educating African Americans, Hispanics, Native Americans, and other groups underrepresented 
in biomedical research.  Research-intensive NCI Cancer Centers, together with culturally 
sensitive minority-serving institutions (MSIs), offer an entirely new set of opportunities for
training more minority scientists, expanding the cancer research capability of MSIs, and focusing 
more research and community outreach programs of Cancer Centers on minority health 
disparities.  In the next year, the MICCP will seek ways to integrate its efforts with NCI’s Special
Populations Networks for Cancer Awareness Research and Training and the Minority 
Biomedical Support Grant Program, sponsored by the National Institute of General Medical 
Sciences at the NIH. 
 
The Comprehensive Minority Biomedical Program (CMBP) aims to increase the number of 
minority scientists in biomedical research and enhance the careers of those already in the field. 
CMBP programs include NCI’s newest training initiative for underserved minorities, the 
Continuing Umbrella of Research Experiences (CURE), and a host of other training 
opportunities targeting high school students through established researchers. Increasing the 
representation of ethnic and minority individuals in research and clinical care is crucial to ensure 
that important research questions about disparities are investigated and that discoveries are 
translated into community practice. 
 
Through its Cancer Centers Program, NCI has established the foundation for an overarching 
research framework that will bring diverse scientific disciplines together across institutional 
boundaries.  NCI-designated Cancer Centers continue to evolve as key strategic partners of NCI.  
In 2001, NCI added a Center in Missouri and will fund a new planning grant for developing a 
Center in South Carolina.  In addition, the number of Cancer Centers with the “Comprehensive” 
designation increased in 2001 to 38.  NCI has also been working with institutions in Missouri, 
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NCI is providing training for new scientists focused on health disparities through the Cancer 
Prevention Fellowship Program and the Special Population Networks for Cancer Awareness 
Research and Training (SPNs).  In the Washington, D.C., area, fellows have research and mentor 
opportunities through the NCI-funded Latin American Cancer Research Coalition SPN.  This 
arrangement provides participants with field experience at Georgetown University and 
Washington Hospital Center.  Similarly, a Cancer Prevention Fellow is working closely with 
investigators at the Johns Hopkins Oncology Center in new prevention and control programs 
targeted to African American men in Baltimore City and Prince George’s County. 
 
In the area of training, a variety of individual and institutional training and career development 
awards are being employed to meet the needs of new and established investigators and NCI’s 
anticipated research priorities.  Special programs have focused increased resources on career 
tracks for M.D.s in cancer research, behavioral and population scientists, minority scientists, and 
scientists in highly technical fields important to the future of cancer research.  Education 
programs for health practitioners and the public are being more effectively integrated and made 
accessible through improved national networking and exploitation of informatics technologies.  
The NCI training activities are varied and include programs aimed at all stages of career 
development.  Included are programs open to all as well as programs specifically tailored to meet 
the needs of minority scientists. 
 
•  Individual National Research Service Awards are aimed at providing a stable cadre of well- 
trained basic scientists from all segments of the population.  
 
•  Individual mentored 5-year awards provide special opportunities for M.D.s in basic or  
clinical research and for individuals pursuing cancer prevention, control, behavioral, and  
population science.  Interest in these awards has increased dramatically over the last 2 years, 
resulting in a three-fold increase in the number granted – evidence of both the need for and 
effectiveness of these programs. 
 
•  Bridging awards encourage basic scientists and minority scientists to pursue careers in cancer  
research.  These awards require recipients to undertake mentored and independent research, 
providing them protected time to develop independent research programs.  These special 
bridging awards have increased steadily since their inception 5 years ago and are on target for 
achieving their strategic objectives. 
 
•  Transition awards provide for 3 years of protected time following mentored postdoctoral  
training or for new investigators to initiate successful research programs. These awards  
are now in place for NCI’s two most critical areas of need: medically trained doctors in 
            basic and clinical research and population scientists.  A new transition award is now 
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Massachusetts, and Michigan to develop Cancer Centers. 
Georgia, New York, Louisiana, Rhode Island, Florida, West Virginia, Kentucky, Arkansas,
and in cancer prevention, control, behavioral, and population sciences protected time to 
conduct research and mentor new scientists.  The number of these awards has increased 
since their introduction, and their availability appears to be helping to curtail the 
migration of physicians from research to patient care.   
 
New diversified sciences career development awards attract technology developers and scientists 
in disciplines not traditionally associated with cancer research but clearly needed for the future. 
Institutional awards are 5-year awards for developing and conducting training and career 
development programs.  These awards achieve special goals by establishing specific 
requirements and assembling mentors whose skills support program objectives. 
 
•  National Research Service Awards, NCI’s mainstay for training basic scientists, include  
special provisions for curriculum and research environments that expose all trainees to 
cancer-related opportunities and important new research approaches of the future.
 
 
•  Institutional Clinical Oncology Career Development Programs prepare the next  
generation of clinical scientists to design and implement hypothesis-based clinical trials 
and to collaborate with basic scientists.  There are now nearly 20 of these programs in 
place throughout the nation. 
 
•  Institutional Education and Career Development Programs, initiated in 2000, prepare 
participants for collaborative, multidisciplinary team research settings.  This program is 
proving to be extremely successful in meeting NCI’s strategic needs by stimulating the  
initiation of new, forward-looking training programs in prevention and control, imaging 
sciences, outcomes research, and molecular pathology. 
 
•  The Continuing Umbrella of Research Experiences (CURE) Program engages minority  
high school and undergraduate students and provides them with assistance through all 
stages of training and career development needed to become independent investigators. 
 
 
•  Minority Institution/Cancer Center Partnerships have the potential to link over 300  
Minority-Serving Institutions with NCI Cancer Centers to increase the number of  
minority students engaged in cancer research; strengthen the research capabilities of 
minority institutions; and support Centers in reducing cancer incidence and mortality in 
minority populations.  Several comprehensive partnerships are now operating, and 
numerous planning activities are being supported to enhance more focused collaborations 
between NCI Cancer Centers and minority-serving institutions.  
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available for minority scientists.  Because we have not been able to achieve our targeted 
objectives for transition awards during their first few years, we are taking new measures  
to increase their accessibility and attractiveness. 
 
•  Established investigator awards provide seasoned investigators in the clinical sciences 
APPENDIX D:  Selected Ongoing Activities to Expand Community Outreach, Information 
Dissemination, and Public Health Education related to the Reduction of Cancer Health 
Disparities  
 
NCI’s Office of Liaison Activities was established to provide a consistent point of contact with 
diverse consumer constituencies, to ensure that the Institute is aware of and responsive to cancer-
related issues affecting specific population groups. 
 
Two new series of cancer patient education materials for low-literacy populations focus on 
information in two areas important to these groups, pain management and clinical trials.  The 
pain management information was adapted from materials developed by the Johns Hopkins 
University Comprehensive Cancer Center.  The clinical trials series was created specifically for 
African American and Native American groups. 
 
NCI collaborated with the Howard University Cancer Center and Meharry Medical College to 
increase access to and involvement in clinical trials by underrepresented populations, minority 
researchers, and patients and physicians who have not previously participated in clinical trials 
research.  NCI provided support for the development of culturally appropriate patient education 
materials and for clinical trials data management infrastructure. 
 
To communicate and promote the use of important information about cancer trends, NCI has 
been improving dissemination and diffusion of data resources and methods.  We have added 
mechanisms that provide important information about cancer trends not only to cancer centers, 
universities, and health departments, but also to cancer advocates and the public. 
 
•  Special resources have been mounted on the Web to make complex national data systems  
  such as SEER much easier to use.  These resources include the Current Population Survey  
Tobacco Use Supplements, the improved SEER-Medicare Linked Database, the
International Dietary Assessment Calibration/Validation Research Register, SEER*Stat, 
SEER*Prep, SATSCAN, CANSURV, COMPREV, the CanQues, and SEER training
Web-hosting services. 
 
•  NCI is examining the potential use of workshops to teach proficient use of  
methodological and statistical applications.  Examples include workshops on using  
analytic methods for complex medical claims data in the SEER-Medicare Linked 
Database and exploration of innovations in statistical methods for surveillance. 
 
•  We are collaborating with public and private partners to organize and streamline data  
collection, statistical methods, and reporting processes.  For example, starting with the  
 36
 Web-based statistical module CanQues, a major international publishing company is 
•  NCI has published the Cancer Progress Report, in hard copy and on the Web, to detail 
  progress in our Nation’s fight against cancer to all Americans. 
 
NCI scientists have also been studying the impact of interventions on cancer trends at state, local, 
and national levels through support of the Cancer Intervention and Surveillance Modeling  
Network (CISNET).  CISNET explores the causes of cancer incidence and mortality trends, 
analyzes whether recommended interventions are working, predicts the impact of new 
interventions, and studies optimal control strategies.  As requested through state health  
departments and American Cancer Society (ACS) divisions, and in collaboration with CDC and 
ACS National, we are building relationships between cancer control planners and CISNET to 
model the impact of disseminating effective interventions on cancer trends.
 
 Planning for the Health Information National Trends Survey (HINTS) of 9,000 participants is 
well underway.  HINTS, to be launched in 2002, will be the only national survey focused on 
cancer communications.  It will gather information on health, sociodemographics, and access to 
health care; knowledge about cancer; risk perceptions; cancer-related behaviors such as cancer
prevention and screening; as well as data on such topics as personal cancer experience, social 
ties, and self-efficacy.  The data will be analyzed and made quickly available to the research 
community to inform future communications research and program planning for cancer as well 
as other health issues.  Data will also be shared with the advocacy community through briefings   
and special reports.  
 
NCI staff are tapping a health/lifestyle information database to identify and disseminate data on  
the information needs of specific audiences, develop appropriate educational messages, and 
identify the best media, locations, and techniques for communicating cancer information.  
Moreover, staff has developed and maintains a NewMediacy listserv that is narrowing the  
knowledge gap between the private and public sectors.   
 
A number of pilot projects and educational materials focus on understanding and bridging the  
digital divide and promoting the benefits of clinical trials.  
 
•  Last year, NCI announced a new initiative and, within the same fiscal year, funded four  
research and development projects to develop unique approaches for overcoming the 
cancer “digital divide” [a term referring to existing disparities in access to and utilization 
of the newer means of communication (e.g., the World Wide Web)] by providing 
underserved groups with access to computers and the wealth of cancer information now 
    
helping to make a “core engine” that can be used online to retrieve cancer statistics.  
Collaborations with the Breast Cancer Surveillance Consortium and the Breast Imaging 
Reporting and Data System Committee of the American College of Radiology are 
releasing the research potential of national mammography screening data by streamlining 
and standardizing data collection instruments and software systems. 
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protection of human participants in research.  
 
•  Our new Cancer Clinical Trials Education Series provides clinical trials information to 
the public, health care professionals, and patient groups.  
 
 
To accelerate research and development of interventions, NCI has taken several steps to address 
the need for more focused interdisciplinary studies in cancer communications: 
 
 
•  We solicited applications for grants to create up to five Centers of Excellence in Cancer 
Communications Research in Fiscal Year 2002.  The response was excellent, showing 
that this initiative meets a real need in the research community.  The Centers are expected  
to accelerate scientific developments in cancer communications, increase the number of  
investigators from a range of disciplines who focus on the study of cancer 
communications, and train interdisciplinary investigators to conduct cutting-edge 
communications research directly relevant to the context of cancer prevention, detection, 
treatment, control, and survivorship. 
 
•  NCI also supported a Community Clinical Oncology Program project based at the  
  University of Rochester to collect data from newly diagnosed cancer patients to learn 
more about their special communication needs.  This information will be used for 
program planning and to assess the need for additional research. 
 
•  NCI World Wide Web sites have been enhanced with an instant messaging service to  
answer cancer questions submitted online, a natural language search system, the online 
NCI Publications Locator, and new minimum standards for improved navigability, 
consistency, and usability. 
 
•  Research organizations, medical professionals, and commercial vendors are using NCI-
provided tools - a glossary that supports the “define terms on this page” function, for 
example - to enhance their ability to communicate cancer information on the World Wide 
Web. 
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•  A Web-based educational program is assisting research teams with issues related to the 
 
•  Research is underway to improve and assess the communication of risks, benefits, and  
other essential elements of the informed consent and decision making and processes.  
.
available through computers.  Each project involves public-private partnerships, and one
has resulted in a joint effort with the Markle Foundation for continued funding 
proficiency.  These include conducting an assessment of public and private initiatives that 
target low-literacy issues and developing an NCI strategic approach that links these 
efforts to the NCI Office for Reducing Cancer-Related Health Disparities.  
  
Several activities illustrate our commitment to improving dissemination of NCI research results.    
We are working to heighten researchers’ understanding about the needs of end users of research
 products from all segments of the population.  We are increasing the usefulness of the products 
so they will benefit all people.  And we have put in place several mechanisms to assist scientists 
in the dissemination of research findings. 
 
To increase the likelihood that all citizens will benefit from our investment in research, we are 
strengthening NCI’s partnerships with voluntary health organizations, HMOs, and community 
organizations, and are planning to fund in 2002 six to eight competitive supplements to NCI 
grantees with effective cancer control interventions ready for dissemination.  
 
We are convening, in collaboration with private organizations and other Federal agencies, an 
interdisciplinary group to develop recommendations for intervention researchers and encourage 
new partnerships among researchers, funders, and receptor organizations.  
 
 
•  As one component of a novel partnership with the National Institute on Drug Abuse and  
the Robert Wood Johnson Foundation (RWJF) for the Transdisciplinary Tobacco Use 
Research Centers (TTURCs), RWJF has funded efforts to assure that research findings 
are communicated quickly to relevant health professionals and organizations and all 
segments of the population.  Through RWJF funding, each TTURC hired a 
communications specialist to facilitate communication with the public, researchers, and 
the media. 
 
•  In partnership with the Agency for Healthcare Research and Quality (AHRQ), we have  
commissioned an evidence-based review of effective strategies to facilitate dissemination 
of cancer-related interventions.  We will communicate the results through the World 
Wide Web, print, and other channels to attempt to reach all segments of the 
population. 
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•  New resources enhance the effectiveness and reach of cancer communications.  An online 
repository of NCI-cleared core information facilitates responses to inquiries from the 
media, public, and other sources.  A new Communication Technologies Research Center 
for usability testing, technology evaluation and demonstration, and training provides the 
tools to design evidence-based cancer information products and services, and a new 
Emerging Technologies Unit searches out and applies new and evolving technologies to 
cancer communications.   
 
•  Plans are in place to ensure access to cancer information for people with limited English 
 
 
To raise the visibility and prominence of cancer communications, the NCI in 2000 established 
the Eleanor Nealon Extraordinary Communicators Lecture and Award Series to pay tribute to 
outstanding communicators.  Awardees speak about their personal and professional experiences 
and are recognized in a public ceremony on the NIH campus. 
 
New NCI education and communications products serve as essential tools for researchers, 
patients, and health care providers.  Recent products include: 
 
 
•  Report of an evidence review of cancer-related decision aids funded through the Agency  
for Healthcare Research and Quality 
•  Understanding Cancer Pain series, developed in collaboration with Johns Hopkins  
  Oncology Center 
•  A searchable Risk Communication Bibliography  
•  Efficacy of Interventions To Modify Dietary Behavior Related to Cancer Risk 
•  5 A Day for Better Health Program Evaluation Report 
•  A pamphlet for the general public on environmental cancers, developed in collaboration 
with the National Institute of Environmental Health Sciences and the National 
Toxicology Program 
•  Materials on the Web and in print to inform seniors and people with disabilities about  
Medicare's new policy to provide coverage for clinical trials, developed through a 
partnership with the Centers for Medicare and Medicaid Services 
•  A new cancer survivorship series, developed through a partnership with the National 
  Coalition for Cancer Survivorship  
•  A booklet on genetic testing to help all people at risk for inherited cancers and those who  
perceive themselves at risk decide whether to explore genetic counseling and testing for  
cancer susceptibility  
•  A booklet to improve the way people think about and make use of data in health decision  
making. 
 
 
NCI has begun several activities aimed at eliminating the so-called digital divide.  NCI is 
supporting four research and development projects to overcome the digital divide by testing the 
efficacy of new communications technologies in cancer prevention and education.  These 
projects involve partnerships among NCI-supported Cancer Centers and Cancer Information 
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•  In partnership with the Centers for Medicare and Medicaid Services, we are helping to 
support a national demonstration to test a new Medicare smoking cessation benefit for 
older smokers, including dissemination of an evidence-based smoking cessation guide for  
smokers ages 50 and older and a guide for Spanish-speaking Medicare beneficiaries.
   
•  In partnership with AHRQ, we are conducting syntheses of the research in a number of  
areas, such as dietary behavior interventions, decision aids, and dissemination. 
 
•  The New England regional CIS office and the Yale University Cancer Center are 
partnering with a Head Start Center, a group concerned with urban policy, and a group 
that supplies computers to children to develop techniques for teaching Head Start parents 
how to use computers and access health information on the Web.   
 
•  The Memorial Sloan Kettering Cancer Center and the New York State regional CIS office  
are partnering to increase access to cancer information and the use of technology 
by residents of an economically depressed area in the community.   
 
•  The University of Wisconsin and the North Central and Mid-West CIS offices are  
collaborating to promote the use of, and training by peer advocates for, a computer-based 
education program among underserved women diagnosed with breast cancer in a rural 
area in one state and an urban area in another.  The project is helping some 280 African 
American women in the urban area play a larger role in their own care by providing them 
with access to online information.  They are being trained in the use of laptop computers 
and are learning to get cancer information and support over the World Wide Web.  These 
patients say it helps them connect with people and information at all hours of the day and 
night, especially when they are worried or have immediate concerns. 
 
•  A collaboration between Louisiana State University and the Mid-South regional office of  
the CIS is examining the use of a low-literacy cancer information computer program to 
determine its potential to increase the use of new communication technologies for health 
information by older adults in a group of senior centers. 
 
NCI is also supporting research in tailored communications. For example, NCI-supported 
researchers have shown that the combination of tailored print materials and a call from a 
telephone health advisor can have several positive effects.  This was the first study to show that 
women’s perceived risks about breast cancer could be changed, and that the changes were 
maintained a year later.  Women who received the combination of tailored communications also 
were more knowledgeable about breast cancer and mammography and were significantly more 
likely to get mammograms. 
 
Another group of NCI-sponsored health communications researchers recently teamed up to 
prepare articles for a special issue of the Journal of Family and Community Health.  They 
reported on their efforts to develop communications for special populations, such as Asians, 
African Americans and Hispanics, and to individualize cancer information.  One team showed 
that focus groups could be conducted through the Internet and therefore could include people 
who would not otherwise participate.  Another group tested the feasibility of a tailored, 
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Service (CIS) Centers at universities and community organizations and programs including Head 
Start, urban and rural community groups, senior centers, and computer suppliers.  We will assess 
the results of the pilot projects and disseminate information about promising interventions. 
NCI will continue efforts to increase knowledge about, tools for, access to, and use of cancer 
communications by the public, consumers, patients, survivors, and health professionals – with a 
special focus on diverse populations – to accelerate reductions in the U.S. cancer burden. 
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interactive computerized cancer pain program for patients.  In pilot research, the majority of 
patients said the computer programs were easy, enjoyable, and informative tools.  The computer 
programs extend the reach of health professionals and permit better reporting of patients’ pain 
and tailored advice based on the patient’s unique pain profile. 
 
   NCI Health Disparities Budget   
   (Dollars in Millions)   
       
        
FY 2002 FY 2003 
Research Infrastructure Outreach Research Infrastructure Outreach 
NCI $198.80 $164.00 $29.60 $222.60 $183.60 $33.20 
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